Very good mention of Arch in article. J&J biggest player. J&J should be looking at partnering or buyout of ARTH I would say. Waiting for price appreciation once CE approval and then hopeful partner and further patents. Just waiting like all. Held price well Friday considering Bio's got hammered. GLTA